Order Article Reprints

Rautenberg C, Bergmann A, Germing U, Fischermanns C, Pechtel S, Kaivers J, Jäger P, Schuler E, Haas R, Kobbe G, et al. Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation. Cancers. 2020; 12(8):2255. https://doi.org/10.3390/cancers12082255

Rautenberg, Christina, Anika Bergmann, Ulrich Germing, Caroline Fischermanns, Sabrina Pechtel, Jennifer Kaivers, Paul Jäger, Esther Schuler, Rainer Haas, Guido Kobbe, and et al. 2020. "Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation" Cancers 12, no. 8: 2255. https://doi.org/10.3390/cancers12082255

Rautenberg, C., Bergmann, A., Germing, U., Fischermanns, C., Pechtel, S., Kaivers, J., Jäger, P., Schuler, E., Haas, R., Kobbe, G., & Schroeder, T. (2020). Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation. Cancers, 12(8), 2255. https://doi.org/10.3390/cancers12082255